Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Chiavari

7 clinical trials in Chiavari, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Chiavari at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Chiavari

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Bayer AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg2 Monoclonal Antibody Against Interleukin-6
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Chiavari

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and management of cardiovascular disease. Research includes evaluation of combination therapies with medications like baxdrostat and dapagliflozin to reduce cardiac events.

  • Heart Failure Prevention
  • Cardiovascular Death Risk Reduction
  • Atherosclerotic Disease Prevention

Advanced trials exploring new approaches to prevent major adverse cardiovascular events in high-risk patients.

02 Metabolic Disorders

Groundbreaking research in Type 2 diabetes management, testing innovative weekly treatment options against traditional daily insulin treatments. Studies focus on glycemic control optimization.

  • Blood Sugar Management
  • Weekly vs Daily Insulin Therapy
  • Combined Treatment Approaches

Investigating the effectiveness of new combination therapies including IcoSema for improved diabetes control.

03 Renal Studies

Comprehensive research into chronic kidney disease treatments, particularly in patients with concurrent conditions. Studies evaluate combination therapies' effectiveness in slowing disease progression.

  • CKD Progression
  • Hypertension Management
  • Diabetic Kidney Disease

Testing novel therapeutic combinations including finerenone and empagliflozin for enhanced kidney protection.

04 Ophthalmology Research

Specialized studies in uveitic macular edema, investigating new intravitreal treatments to improve visual outcomes in affected patients.

  • Visual Acuity Improvement
  • Macular Edema Treatment
  • Intravitreal Therapy

Evaluating innovative treatments for better management of eye conditions affecting central vision.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.